Lenalidomide cutaneous adverse event: a case of Stevens-Johnson syndrome (SJS) in a primary plasma cell leukaemia patient treated with lenalidomide and dexamethasone

Support Care Cancer. 2012 Jul;20(7):1585-7. doi: 10.1007/s00520-012-1481-0. Epub 2012 May 5.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Dexamethasone / administration & dosage
  • Drug Eruptions / diagnosis
  • Drug Eruptions / etiology
  • Drug Eruptions / pathology
  • Humans
  • Lenalidomide
  • Leukemia, Plasma Cell / drug therapy
  • Leukemia, Plasma Cell / pathology
  • Male
  • Middle Aged
  • Stevens-Johnson Syndrome / chemically induced*
  • Stevens-Johnson Syndrome / diagnosis
  • Stevens-Johnson Syndrome / pathology
  • Thalidomide / administration & dosage
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*

Substances

  • Thalidomide
  • Dexamethasone
  • Lenalidomide